A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplantChristopher E. Dandoy, Sonata Jodele, Kasiani C. Myers et al.|Blood Advances|2020Cited by 92
Alternative-Donor Hematopoietic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide for Nonmalignant DisordersOrly R. Klein, Heather J. Symons, Elias T. Zambidis et al.|Biology of Blood and Marrow Transplantation|2016Cited by 76
Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic MalignanciesOrly R. Klein, Heather J. Symons, Elias T. Zambidis et al.|Biology of Blood and Marrow Transplantation|2016Cited by 73
Single-Agent Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis after Human Leukocyte Antigen–Matched Related Bone Marrow Transplantation for Pediatric and Young Adult Patients with Hematologic MalignanciesElad Jacoby, Heather J. Symons, Elias T. Zambidis et al.|Biology of Blood and Marrow Transplantation|2015Cited by 46
Vascular progenitors generated from tankyrase inhibitor-regulated naïve diabetic human iPSC potentiate efficient revascularization of ischemic retinaTea Soon Park, Elias T. Zambidis, Rhonda Grebe et al.|Nature Communications|2020Cited by 25